KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update

December 15, 2023

https://www.globenewswire.com/news-release/2023/11/13/2779004/0/en/KALA-BIO-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html

— Enrollment ongoing in CHASE Phase 2b clinical trial of KPI-012 for PCED; topline data expected in 2H 2024 —
— As of September 30, 2023, $56.1 million in cash and cash equivalents; together with anticipated remaining funding from CIRM award, expected to fund operations into 2Q 2025 —

Read more at globenewswire.com

Related news for (KALA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.